1655-51-2 Usage
Description
DNP-L-TRYPTOPHAN is a chemical compound derived from the amino acid tryptophan, characterized by its distinctive 2,4-dinitrophenyl (DNP) group attached to the L-tryptophan molecule. This modification endows DNP-L-TRYPTOPHAN with unique properties that make it valuable in various scientific and pharmaceutical applications.
Used in Research Applications:
DNP-L-TRYPTOPHAN is used as a research tool for studying the structure and function of proteins, particularly those containing tryptophan residues. Its DNP group allows for enhanced detection and tracking of proteins in various assays and experiments, providing insights into protein dynamics and interactions.
Used in Pharmaceutical Development:
DNP-L-TRYPTOPHAN serves as a precursor in the synthesis of tryptophan-containing peptides and proteins, which are crucial for the development of novel pharmaceuticals. Its role in this process is vital for creating new drugs with potential therapeutic benefits.
Used in Biochemistry and Molecular Biology:
In the field of biochemistry and molecular biology, DNP-L-TRYPTOPHAN is utilized to investigate the relationship between protein structure and function. Its unique properties facilitate the exploration of the potential therapeutic applications of tryptophan-containing compounds, contributing to the advancement of medical treatments.
Overall, DNP-L-TRYPTOPHAN is a versatile compound with applications spanning research, pharmaceutical development, and the study of protein structure and function, highlighting its importance in the scientific and medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1655-51-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,5 and 5 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1655-51:
(6*1)+(5*6)+(4*5)+(3*5)+(2*5)+(1*1)=82
82 % 10 = 2
So 1655-51-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H14N4O6/c22-17(23)15(7-10-9-18-13-4-2-1-3-12(10)13)19-14-6-5-11(20(24)25)8-16(14)21(26)27/h1-6,8-9,15,18-19H,7H2,(H,22,23)
1655-51-2Relevant articles and documents
Direct resolution of optically active isomers on chiral packings containing ergoline skeletons. 5. Enantioseparation of amino acid derivatives
Messina,Girelli,Flieger,Sinibaldi,Sedmera,Cvak
, p. 1191 - 1196 (2007/10/03)
A new procedure for ergot alkaloid-based chiral stationary phase preparation is described. Synthesis is based on bonding the allyl derivative of terguride to mercaptopropylsilanized silica gel. The packing exhibits higher content of chiral selector, stability, reproducibility, and enantioselectivity toward amino acids compared to that previously studied. The chromatographic behavior of amino acids with different side chains and substituent groups is investigated in order to obtain a deeper insight into the enantiodiscriminative mechanism as well as to determine the limitations and strengths of terguride as a chiral selector for this class of compounds. A variety of factors, including mobile phase parameters such as pH, ionic strength, content and nature of organic modifier, and temperature, are examined. A new procedure for ergot alkaloid-based chiral stationary phase preparation is described. Synthesis is based on bonding the allyl derivative of terguride to mercaptopropylsilanized silica gel. The packing exhibits higher content of chiral selector, stability, reproducibility, and enantioselectivity toward amino acids compared to that previously studied. The chromatographic behavior of amino acids with different side chains and substituent groups is investigated in order to obtain a deeper insight into the enantiodiscriminative mechanism as well as to determine the limitations and strengths of terguride as a chiral selector for this class of compounds. A variety of factors, including mobile phase parameters such as pH, ionic strength, content and nature of organic modifier, and temperature, are examined.
